MÆDICA - a Journal of Clinical Medicine Logo
  • Home
  • Profile
  • Standards
    • Types of articles
    • Instructions for authors
    • Editing rules (peer-review protocol)
    • Official Journal’s protocols
  • Editorial Council
  • Peer-review TEAM
  • How to
  • Menu

Author archives

  • About
  • Latest Posts

Laurentia GALES

Latest posts by Laurentia GALES (see all)

  • Relationship between Tumor Infiltrating Lymphocytes and Progression in Breast Cancer - December 21, 2018

Articles signed on MÆDICA, JCM:

Relationship between Tumor Infiltrating Lymphocytes and Progression in Breast Cancer

SELECT ISSUE


MÆDICA - a Journal of Clinical Medicine | Vol. 13, nr. 4, 2018
CNCSIS - CMR - B+ OBBCSSR

Members Area


Relationship between Tumor Infiltrating Lymphocytes and Progression in Breast Cancer

Anca ZGURA, Laurentia GALES, Elvira BRATILA and Rodica ANGHEL

ABSTRACT

The immune system is very critical in suppression of cancer development. The composition of breast cancer-infiltrating lymphocytes has been widely investigated so far and it is accepted that the presence of high tumor-infiltrating lymphocytes (TILs) is associated with improved prognoses. The correlation between various TIL subpopulations and experimentally observed responses is still characterized by a certain grade of controversy. Modulating the immune system is promising treatment strategy in breast cancer, particularly in HER2 positive and triple-negative molecular subtypes. However, there is still much to be done to implement immunotherapy in this disease.
Keywords: tumor-infiltrating lymphocytes, breast cancer, immunotherapy, HER2

Full text | PDF



plic-mail[email protected]

 Terms and conditions

© MÆDICA - a Journal of Clinical Medicine - All rights reserved